Claritas Pharmaceuticals, Inc. (CLAZF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 16, 2025
Claritas Pharmaceuticals Market Cap
Claritas Pharmaceuticals has a market cap or net worth of $38 as of January 23, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
38.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
0.00
Stock Price
$0.00
Market Cap Chart
Since January 11, 2017, Claritas Pharmaceuticals's market cap has decreased from 56.78M to 38.00, a decrease of -100.00%. That is a compound annual growth rate of -79.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 38.00 | - |
| Dec 24, 2024 | 38.00 | -98.66% |
| Dec 28, 2023 | 2.83K | -99.25% |
| Dec 30, 2022 | 377.87K | -92.96% |
| Dec 31, 2021 | 5.37M | -72.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genocea Biosciences | 59.00 |
| Panacos Pharmaceuticals | 54.00 |
| Baudax Bio | 52.00 |
| Core One Labs | 47.00 |
| Mymetics | 46.00 |
| Tengion | 40.00 |
| Comera Life Sciences Holdings | 31.00 |
| Neurobiological Technologies | 27.00 |